Key words: atrial fibrillation, cardioversion, cardiac rhythm management, antiarrhythmic drugs.
About the AuthorAleksei V. Tarasov 1
1 National Health and Research Center of Preventive Healthcare, Moscow, Russia
For citation:Tarasov A.V. Efficiency and safety of pharmacological cardioversion for atrial fibrillation. Clinical review for general practice. 2021; 4: 11–13. DOI: 10.47407/kr2021.2.4.00055
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.